GSA expands OASIS+ with 5 new service domains, streamlining federal procurement and boosting opportunities for small business ...
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental ...
Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) ("QIMC" or the "Company") is pleased to announce a ...
Janux Therapeutics ( JANX) on late Monday reported positive updated interim data for its JANX007, a PSMA-directed TRACTr, ...
CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase 3 trials for the subcutaneous formulation set to begin later in Q2 2025. Additionally, enrollment ...
Completion of Fall 2025 Prospecting Program Across Seigneurie, Bardy, Blanchette and Sabot PropertiesCarbonatite Boulders and Pegmatite Zones Identified 262 Samples Submitted for Analysis Vancouver, ...
SOUTH SAN FRANCISCO, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize ...
Minaurum Gold Inc. (TSXV: MGG) (OTCQX: MMRGF) (“Minaurum” or the “Company”) is pleased to announce its plans to expand the ...